Article
Serologic response to human papillomavirus genotypes following vaccination: findings from the HITCH cohort study.
Infectious diseases (London, England) - 1 Jan 2024
Morais Samantha, Wissing Michel D, Khosrow-Khavar Farzin, Burchell Ann N, Tellier Pierre-Paul, Coutlée François, Waterboer Tim, El-Zein Mariam, Franco Eduardo L
Abstract excerpt
BACKGROUND: Human papillomavirus (HPV) infection contributes to approximately 5% of the worldwide cancer burden. The three-dose HPV vaccine has demonstrated immunogenicity and efficacy. Humoral responses may be critical for preventing, controlling, and/or eliminating HPV infection. Using data from the HITCH cohort, we analysed humoral immune response to HPV vaccination among women in relation to the phylogenetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
